PCBL Chemical reported a robust start to FY27, with consolidated net profit after tax (PAT) surging 64.7% year-on-year to ₹154.93 crore for the quarter ended June 30, 2026. The growth was underpinned by a 17% increase in revenue from operations to ₹2,473.37 crore. On July 29, 2026, the Board of Directors approved these unaudited standalone and consolidated financial results and declared an interim dividend of ₹4.50 per equity share, reflecting strong operational momentum and cash generation capabilities.

The Board meeting, held pursuant to Regulations 30, 33, 51, and 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, also noted that the statutory auditors, S.R. Batliboi & Co. LLP, issued an unmodified limited review report on the financial statements. The record date for the interim dividend payment is fixed for August 4, 2026. Shareholders holding shares on this date will be eligible for the payout.

Financial Performance Highlights

PCBL Chemical’s top-line growth was broad-based across its core segments. Revenue from operations climbed to ₹2,473.37 crore from ₹2,114.05 crore in Q1FY26. This expansion contributed to a significant improvement in profitability, with PAT rising from ₹94.10 crore to ₹154.93 crore. The company’s operating margin expanded to 14.76% from 13.85% in the corresponding period last year, indicating improved cost efficiency despite higher input costs.

Segment-Wise Contribution

The Carbon Black segment remained the primary driver of revenue, contributing ₹2,003.93 crore to the total segment revenue of ₹2,508.76 crore. The Chemical segment also saw healthy growth, with revenues reaching ₹393.83 crore compared to ₹382.54 crore in Q1FY26. The Power segment generated ₹111.00 crore in revenue. Segment profit before interest and tax (PBIT) stood at ₹405.41 crore, a substantial increase from ₹308.96 crore in the previous year’s quarter, highlighting strong underlying operational performance across business units.

Balance Sheet and Debt Metrics

As of June 30, 2026, PCBL Chemical maintained a consolidated debt-equity ratio of 1.25, slightly up from 1.20 at the end of FY26. The company has an outstanding non-convertible debenture (NCD) amount of ₹490 crore, secured by a pledge over shares of its subsidiary, Aquapharm Chemical Limited. Additionally, the subsidiary Aquapharm Chemical Limited has ₹385 crore in outstanding NCDs. The group’s debt service coverage ratio (without prepayment) improved significantly to 2.31 from 1.76 in Q1FY26, demonstrating enhanced ability to meet debt obligations from operating profits.

What the Numbers Show

The divergence between revenue growth (17%) and profit growth (65%) underscores a period of margin expansion for PCBL Chemical. The operating margin improvement of 91 basis points suggests that the company successfully passed on higher costs or benefited from favorable product mix dynamics. Furthermore, the declaration of an interim dividend of ₹4.50 per share signals management’s confidence in sustained cash flows and commitment to shareholder returns amidst a strong earnings backdrop.

PCBL Chemical has announced that its Q1FY27 earnings conference call will be held on July 29, 2026, at 17:00 IST. The event is designed to provide investors and analysts with a detailed overview of the company’s financial and operational performance for the first quarter of fiscal year 2027. This scheduled disclosure follows the company's recent financial reporting cycle, offering stakeholders a direct channel to engage with senior leadership regarding quarterly outcomes.

Earnings Call Details

The conference call will be conducted pursuant to Regulations 30 and 46(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The session aims to clarify performance metrics and strategic updates without sharing any unpublished price-sensitive information (UPSI) prior to the formal discussion.

Management Participation

Senior executives from PCBL Chemical Limited will lead the discussion, providing insights into the company's recent results. The key participants include:

• Nilesh Koul, Managing Director
• Rohit Narang, CEO Aquapharm Chemical
• Raj Gupta, CFO
• Pankaj Kedia, Executive Director - IR

The call is being coordinated by ICICI Securities, which has issued invitations to investors and analysts. Participants can register via the Diamond Pass link provided in the official notice. For logistical support, ICICI Securities has designated contact points including Jaideep Goswami, Head of Equities, and other team members such as Sanjesh Jain, Mohit Mishra, Rushad Kapadia, Seema Sehgal, and Minali Ginwala.

Regulatory Compliance

PCBL Chemical Limited submitted the intimation to the National Stock Exchange of India Ltd and BSE Ltd on July 24, 2026. The disclosure was signed by Kaushik Mukherjee, Company Secretary and Chief Legal Officer, affirming compliance with SEBI Listing Regulations. The company noted that the schedule is subject to change due to exigencies, if any, though no alterations have been reported as of the filing date.

What the Numbers Show

While specific financial figures for Q1FY27 have not been disclosed in this notice, the scheduling of the call indicates the completion of the quarter's audit and finalization of accounts. Investors should monitor the call for details on revenue growth, margin trends, and operational efficiencies in the chemical and pharmaceutical segments, particularly given the active participation of the CEO of Aquapharm Chemical, suggesting potential segment-specific updates.